RNF130 Antibody
-
中文名稱:RNF130兔多克隆抗體
-
貨號:CSB-PA004016
-
規(guī)格:¥880
-
圖片:
-
其他:
產(chǎn)品詳情
-
Uniprot No.:
-
基因名:
-
別名:RNF130 antibody; E3 ubiquitin-protein ligase RNF130 antibody; EC 2.3.2.27 antibody; Goliath homolog antibody; H-Goliath antibody; RING finger protein 130 antibody; RING-type E3 ubiquitin transferase RNF130 antibody
-
宿主:Rabbit
-
反應種屬:Human,Mouse,Rat
-
免疫原:Synthesized peptide derived from the C-terminal region of Human RNF130.
-
免疫原種屬:Homo sapiens (Human)
-
標記方式:Non-conjugated
-
抗體亞型:IgG
-
純化方式:The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
濃度:It differs from different batches. Please contact us to confirm it.
-
保存緩沖液:Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
-
產(chǎn)品提供形式:Liquid
-
應用范圍:WB, ELISA
-
推薦稀釋比:
Application Recommended Dilution WB 1:500-1:2000 ELISA 1:5000 -
Protocols:
-
儲存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
相關(guān)產(chǎn)品
靶點詳情
-
功能:May have a role during the programmed cell death of hematopoietic cells. Acts as an E3 ubiquitin-protein ligase.
-
基因功能參考文獻:
- GOLIATH, a paralog of GRAIL, is a new E3 ligase protein, expressed in leukocytes. PMID: 16549277
- Cloning and functional analysis of the rat counterpart. PMID: 13679316
- Cloning and functional analysis of the mouse counterpart. PMID: 10806348
-
亞細胞定位:Membrane; Single-pass type I membrane protein. Cytoplasm.
-
組織特異性:Ubiquitously expressed. Highly expressed in leukocytes. Not expressed in erythroblasts.
-
數(shù)據(jù)庫鏈接:
Most popular with customers
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
-